FAQ

Refractory Adult Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia that occurs in adulthood and does not respond to treatment.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2012
0119862012

Related topics

Related topics

14 relations
Atypical lymphocyteBone MarrowHematopoietic and Lymphatic SystemHematopoietic and Lymphoid Cell
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Refractory Adult Acute Lymphoblastic Leukemia
cancer cell
Bone Marrow
Lymphadenopathy
Neoplastic Cell
Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
The present study reports the Spanish PETHEMA group experience in 31 heavily pretreated relapsed/refractory acute lymphoblastic… (More)
  • table I
  • table II
  • table III
  • figure 1
Is this relevant?
2009
2009
A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia.
e18002 Background: Most patients with adult ALL eventually relapse. Salvage regimens in these patients and in patients with… (More)
Is this relevant?
2006
2006
Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG)
Outcome of adults with acute lymphoblastic leukemia (ALL) who fail to achieve complete remission (CR) or who relapse soon after… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
Is this relevant?
2000
2000
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.
PURPOSE The Southwest Oncology Group performed a Phase II study to investigate the effectiveness of an induction regimen of high… (More)
Is this relevant?
1998
1998
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
Relapsed or refractory adult acute lymphoblastic leukemia (ALL) carries a grave prognosis. The most promising strategy for curing… (More)
  • table 2
Is this relevant?
1986
1986
Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study.
Methotrexate (MTX) and L-asparaginase (ASP) are effective agents in the treatment of acute lymphoblastic leukemia (ALL). The… (More)
Is this relevant?